Tag: M&A

January 20, 2017 Off

Sanofi’s M&A misses frustrate some investors in drugmaker

By Dino Mustafić

For the last year, Sanofi’s chief executive has made clear his quest for deals to help revive the fortunes of France’s biggest drugmaker.

The market is still waiting. Olivier Brandicourt’s failure to land two big biotech acquisitions he was chasing has led to growing impatience among some investors.

December 30, 2016 Off

Corporate makeovers drive corporate takeovers in 2016 M&A bonanza

By Dino Mustafić

In 2016, mega deals became ever more transformative.
German drug and crop chemical maker Bayer AG announced its $66 billion takeover of U.S. agrochemicals company Monsanto Co, while ChemChina signed a $43 billion acquisition of Swiss seeds group Syngenta AG, as consolidation in the sector intensified.